• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[蛋白酪氨酸激酶介导的信号转导与抗肿瘤药物]

[Signal transduction by protein tyrosine kinases and antitumor agents].

作者信息

Mao Yong-Jun, Li Hai-Hong, Li Jian-Feng, Shen Jing-Shan

机构信息

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Yao Xue Xue Bao. 2008 Apr;43(4):323-34.

PMID:18664191
Abstract

Intracellular signal transduction plays an important role in the process of cellular metabolism, segmentation, differentiation, biological behaviour and cell death. Overactive signal transduction relates to tumor development and progression. Signaling pathways operated by protein tyrosine kinases (PTKs) will be illuminated here briefly. The Ras/Raf/MAPK and PI-3K/Akt pathways through receptor protein tyrosine kinases (RTKs), the Src, Bcr-Abl and JAK/STAT pathways by non-receptor protein tyrosine kinases (nrPTKs) are shown separately. Antitumor agents targeting the key proteins involved in the above five signalling routes are also summarized in this review.

摘要

细胞内信号转导在细胞代谢、分裂、分化、生物学行为及细胞死亡过程中发挥着重要作用。信号转导过度活跃与肿瘤的发生和发展相关。本文将简要阐述由蛋白酪氨酸激酶(PTK)介导的信号通路。通过受体蛋白酪氨酸激酶(RTK)介导的Ras/Raf/MAPK和PI-3K/Akt信号通路,以及由非受体蛋白酪氨酸激酶(nrPTK)介导的Src、Bcr-Abl和JAK/STAT信号通路将分别展示。本文还总结了针对上述五条信号通路中关键蛋白的抗肿瘤药物。

相似文献

1
[Signal transduction by protein tyrosine kinases and antitumor agents].[蛋白酪氨酸激酶介导的信号转导与抗肿瘤药物]
Yao Xue Xue Bao. 2008 Apr;43(4):323-34.
2
New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.抗癌治疗的新范式:用激酶抑制剂靶向多种信号通路。
Semin Oncol. 2006 Aug;33(4):407-20. doi: 10.1053/j.seminoncol.2006.04.005.
3
Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.非受体和受体酪氨酸激酶(TKs)在α-二氟甲基鸟氨酸(DFMO)对乳腺癌细胞的抗肿瘤作用中的作用
Breast Cancer Res Treat. 2008 Nov;112(2):255-61. doi: 10.1007/s10549-007-9866-3. Epub 2007 Dec 21.
4
Oncogenic kinase signalling.致癌激酶信号传导
Nature. 2001 May 17;411(6835):355-65. doi: 10.1038/35077225.
5
Crosstalk between G protein-coupled receptors and tyrosine kinase signaling: Src take centre stage.G蛋白偶联受体与酪氨酸激酶信号传导之间的串扰:Src成为焦点。
Arch Immunol Ther Exp (Warsz). 2000;48(1):27-30.
6
Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.酪氨酸激酶受体/血小板衍生生长因子受体β通过Ras/ERK和STAT5信号通路诱导干细胞分化。
Exp Hematol. 2009 Jan;37(1):111-121. doi: 10.1016/j.exphem.2008.09.012.
7
Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.胰岛素样生长因子-I受体信号转导与Janus激酶/信号转导子和转录激活子(JAK-STAT)通路。
Biofactors. 2009 Jan-Feb;35(1):76-81. doi: 10.1002/biof.20.
8
Tyrosine kinases in megakaryocytopoiesis.
Stem Cells. 1995 Jul;13(4):380-92. doi: 10.1002/stem.5530130409.
9
The interplay between Src family kinases and receptor tyrosine kinases.Src家族激酶与受体酪氨酸激酶之间的相互作用。
Oncogene. 2004 Oct 18;23(48):7957-68. doi: 10.1038/sj.onc.1208079.
10
Localization of receptor-mediated signal transduction pathways: the inside story.受体介导信号转导通路的定位:内幕故事。
Mol Interv. 2002 Sep;2(5):292-307. doi: 10.1124/mi.2.5.292.

引用本文的文献

1
[Anti-tumor mechanism of sesquiterpenoids from based on molecular docking].基于分子对接的[来源植物名称]倍半萜类化合物抗肿瘤机制研究 (原文中“from ”部分缺少具体植物名称)
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Jan 20;42(1):71-77. doi: 10.12122/j.issn.1673-4254.2022.01.08.
2
Mytoxin B and Myrothecine A Induce Apoptosis in Human Hepatocarcinoma Cell Line SMMC-7721 via PI3K/Akt Signaling Pathway.蜂毒素 B 和米托蒽醌 A 通过 PI3K/Akt 信号通路诱导人肝癌细胞系 SMMC-7721 凋亡。
Molecules. 2019 Jun 20;24(12):2291. doi: 10.3390/molecules24122291.
3
[Inhibitory effect of apatinib on HCT-116 cells and its mechanism].
阿帕替尼对HCT-116细胞的抑制作用及其机制
Nan Fang Yi Ke Da Xue Xue Bao. 2017 Mar 20;37(3):367-372. doi: 10.3969/j.issn.1673-4254.2017.03.15.
4
Harnessing benefit from targeting tumor associated carbohydrate antigens.通过靶向肿瘤相关碳水化合物抗原获取益处。
Hum Vaccin Immunother. 2017 Feb;13(2):323-331. doi: 10.1080/21645515.2017.1264789.